Cargando…

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy

PURPOSE: This study examined clinical and economic outcomes among patients with advanced hepatocellular carcinoma (HCC) treated with systemic agents by line of therapy. METHODS: Adults with ≥ 2 medical claims for primary diagnosed HCC (from January 1, 2008, through September 30, 2015) and ≥ 1 claim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonafede, Machaon M., Korytowsky, Beata, Singh, Prianka, Cai, Qian, Cappell, Katherine, Jariwala-Parikh, Krutika, Sill, Bruce, Parikh, Neehar D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000498/ https://www.ncbi.nlm.nih.gov/pubmed/31011982 http://dx.doi.org/10.1007/s12029-019-00230-z

Ejemplares similares

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

A Linked Electronic Medical Record-Claims Analysis of the Clinical and Economic Outcomes of Patients Coded for Erosive Esophagitis in the United States
por: Yadlapati, Rena, et al.
Publicado: (2023)

Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
por: Soliman, Ahmed M., et al.
Publicado: (2018)

Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016–2019
por: Shah, Shailja, et al.
Publicado: (2023)

Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women
por: Tran, Oth, et al.
Publicado: (2021)

Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women
por: Tran, Oth, et al.
Publicado: (2022)

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
por: Bowen, James, et al.
Publicado: (2020)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis
por: Marshall, Alexander, et al.
Publicado: (2019)

Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
por: Johnson, Barbara H., et al.
Publicado: (2015)

Contemporary management of pain in cirrhosis: Toward precision therapy for pain
por: Holman, Alexis, et al.
Publicado: (2023)

Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy
por: Soliman, Ahmed M., et al.
Publicado: (2016)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference study
por: Parikh, Neehar D., et al.
Publicado: (2023)

Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis
por: Bonafede, Machaon, et al.
Publicado: (2015)

Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
por: Fox, Robert J., et al.
Publicado: (2022)

The economic burden of constipation therapy
por: Albu, Anamaria, et al.
Publicado: (2019)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

The Magnitude of the Health and Economic Impact of Increased Organ Donation on Patients With End-Stage Renal Disease
por: Chen, Huey-Fen, et al.
Publicado: (2021)

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
por: Tapper, Elliot B, et al.
Publicado: (2018)

Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera
por: Parasuraman, Shreekant V., et al.
Publicado: (2018)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
por: Polsky, Daniel, et al.
Publicado: (2012)

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
por: Yang, Ming, et al.
Publicado: (2020)

Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia
por: Lauriello, John, et al.
Publicado: (2021)

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
por: Bonafede, Machaon M, et al.
Publicado: (2013)

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
por: Johnson, Barbara H, et al.
Publicado: (2016)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
por: Bonafede, Machaon, et al.
Publicado: (2021)

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
por: Au, Trang H., et al.
Publicado: (2021)

Alternative therapy in glaucoma management: Is there any role?
por: Parikh, Rajul S, et al.
Publicado: (2011)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
por: Au, Trang H., et al.
Publicado: (2021)

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017)

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data
por: Gharaibeh, Mahdi, et al.
Publicado: (2020)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uene1q0ar3mijjp9hnjbpe2u1h